Sydney Morning Herald

AsiaPac · 3 hrs ago

✦ 75◉ Centre

Perth biotech Syngenis unleashes AI drug discovery push

75Credibility

0Ratings

0Comments

AI Analysis

Credibility 75/100

Partisan intensity 35/100

ObjectivePartisan

◉ Centre ✓ Fair headline

Perth-based biotech company Syngenis is leveraging artificial intelligence to accelerate the discovery of RNA therapies and reduce associated costs, positioning itself to compete in the expanding global RNA therapy market.

🔒www.smh.com.au

Score: 75Opens in app

Perth biotech Syngenis unleashes AI drug discovery push

Sydney Morning Herald · 3 hrs ago

Perth biotech Syngenis is using AI to slash the time and cost of discovering RNA therapies, targeting a booming global market that is reshaping modern medicine.

Discussion 0 comments

Sort:

No comments yet — be the first to start the discussion!